192 related articles for article (PubMed ID: 37489813)
21. Norharmane rhenium(I) polypyridyl complexes: synthesis, structural and spectroscopic characterization.
Maisuls I; Wolcan E; Piro OE; Etcheverría GA; Petroselli G; Erra-Ballsels R; Cabrerizo FM; Ruiz GT
Dalton Trans; 2015 Oct; 44(39):17064-74. PubMed ID: 26365709
[TBL] [Abstract][Full Text] [Related]
22. Iridium(III) complexes entrapped in liposomes trigger mitochondria-mediated apoptosis and GSDME-mediated pyroptosis.
Zhang H; Liao X; Wu X; Shi C; Zhang Y; Yuan Y; Li W; Wang J; Liu Y
J Inorg Biochem; 2022 Mar; 228():111706. PubMed ID: 35033830
[TBL] [Abstract][Full Text] [Related]
23. X-Ray fluorescence microscopy reveals that rhenium(i) tricarbonyl isonitrile complexes remain intact in vitro.
Konkankit CC; Lovett J; Harris HH; Wilson JJ
Chem Commun (Camb); 2020 Jun; 56(48):6515-6518. PubMed ID: 32432584
[TBL] [Abstract][Full Text] [Related]
24. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria-Accumulating Rhenium(I) Tricarbonyl Complexes Induce Cell Death via Irreversible Oxidative Stress and Glutathione Metabolism Disturbance.
Wang FX; Liang JH; Zhang H; Wang ZH; Wan Q; Tan CP; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13123-13133. PubMed ID: 30888144
[TBL] [Abstract][Full Text] [Related]
26. Aminoquinoline-based Re(I) tricarbonyl complexes: Insights into their antiproliferative activity and mechanisms of action.
Zinman PS; Welsh A; Omondi RO; Khan S; Prince S; Nordlander E; Smith GS
Eur J Med Chem; 2024 Feb; 266():116094. PubMed ID: 38219660
[TBL] [Abstract][Full Text] [Related]
27. Ruthenium (II) Complexes of Mono-, Di- and Tripodal Polypyridine Ligands: Synthesis, Characterization, and Spectroscopic Studies.
Obali AY; Ucan HI
J Fluoresc; 2015 May; 25(3):647-55. PubMed ID: 25779940
[TBL] [Abstract][Full Text] [Related]
28. Exploring the In Vivo and In Vitro Anticancer Activity of Rhenium Isonitrile Complexes.
Marker SC; King AP; Granja S; Vaughn B; Woods JJ; Boros E; Wilson JJ
Inorg Chem; 2020 Jul; 59(14):10285-10303. PubMed ID: 32633531
[TBL] [Abstract][Full Text] [Related]
29. pH luminescence switching, dihydrogen phosphate sensing, and cellular uptake of a heterobimetallic ruthenium(II)-rhenium(I) complex.
Zheng ZB; Wu YQ; Wang KZ; Li F
Dalton Trans; 2014 Feb; 43(8):3273-84. PubMed ID: 24356444
[TBL] [Abstract][Full Text] [Related]
30. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)
Rubio AR; Fidalgo J; Martin-Vargas J; Pérez-Arnaiz C; Alonso-Torre SR; Biver T; Espino G; Busto N; García B
J Inorg Biochem; 2020 Feb; 203():110885. PubMed ID: 31731049
[TBL] [Abstract][Full Text] [Related]
31. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
32. Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi.
Rodríguez Arce E; Machado I; Rodríguez B; Lapier M; Zúñiga MC; Maya JD; Olea Azar C; Otero L; Gambino D
J Inorg Biochem; 2017 May; 170():125-133. PubMed ID: 28237731
[TBL] [Abstract][Full Text] [Related]
33. Understanding the photophysical properties of rhenium(I) compounds coordinated to 4,7-diamine-1,10-phenanthroline: synthetic, luminescence and biological studies.
Ramos LD; de Macedo LH; Gobo NRS; de Oliveira KT; Cerchiaro G; Morelli Frin KP
Dalton Trans; 2020 Nov; 49(45):16154-16165. PubMed ID: 32270852
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation of novel iridium(III) complexes targeting mitochondria toward melanoma B16 cells.
Yuan Y; Zhang Y; Chen J; Huang C; Liu H; Li W; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2023 Feb; 247():115046. PubMed ID: 36577214
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies of substitution reactions of rhenium(I) dicarbonyl-nitrosyl and tricarbonyl complexes in aqueous media.
Marti N; Spingler B; Breher F; Schibli R
Inorg Chem; 2005 Aug; 44(17):6082-91. PubMed ID: 16097829
[TBL] [Abstract][Full Text] [Related]
36. Systematically altering the lipophilicity of rhenium(I) tricarbonyl anticancer agents to tune the rate at which they induce cell death.
Konkankit CC; Vaughn BA; Huang Z; Boros E; Wilson JJ
Dalton Trans; 2020 Nov; 49(45):16062-16066. PubMed ID: 32319485
[TBL] [Abstract][Full Text] [Related]
37. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
[TBL] [Abstract][Full Text] [Related]
38. Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable In Vitro Cytotoxicity and Anti-inflammatory Effects.
Vančo J; Trávníček Z; Hošek J; Malina T; Dvořák Z
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299247
[TBL] [Abstract][Full Text] [Related]
39. Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation.
Xie FL; Wang Y; Zhu JW; Xu HH; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2022 Dec; 237():112011. PubMed ID: 36252336
[TBL] [Abstract][Full Text] [Related]
40. Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.
Pietzsch HJ; Gupta A; Reisgys M; Drews A; Seifert S; Syhre R; Spies H; Alberto R; Abram U; Schubiger PA; Johannsen B
Bioconjug Chem; 2000; 11(3):414-24. PubMed ID: 10821659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
